ClinicalTrials.gov
public full text
Public Domain
Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts
The purpose of this study is to compare the recurrence rate following total clearance of external genital warts (EGWs) when clearance has been obtained by imiquimod (3 applications per week for 4 weeks) followed by ablative therapy (laser or electrocautery therapy) with that from just ablative therapy treatment alone.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts#1151924
- Carbon Dioxide Laser and Cryotherapy in Treatment of Warts#916470
- Immunologic Profile of Chronically Photodamaged Skin#831967
- Exploratory Clinical Study of cCTL in Combination With Immunotherapy for Advanced Gynecologic Malignancies#121374
- ID HBV Vaccination With Imiquimod in OBI#238186
Record · ID 826472
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive